SCRI Development Innovations, LLC

10 results found.

Multiple Myeloma Clinical Trial using carfilzomib and panobinostat

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- Phase I/II Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma.
carfilzomib and panobinostat

HER2 Positive Esophagogastric Cancer Clinical Trial using 5-Fluorouracil; Oxaliplatin; Lapatinib; Radiation Therapy

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- A Phase II Study With Lead-in Safety Cohort of 5-Fluorouracil, Oxaliplatin and Lapatinib in Combination With Radiation Therapy as Neoadjuvant Treatment for Patients With Localized HER2 Positive Esophagogastric Adenocarcinomas.
5-Fluorouracil; Oxaliplatin; Lapatinib; Radiation Therapy

Glioblastoma Multiforme Clinical Trial using Bevacizumab; BKM120

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- Phase I/II Study of the Combination of BKM120 and Bevacizumab in Patients With Refractory Solid Tumors (Phase I) and Relapsed/Refractory Glioblastoma Multiforme (Phase II).
Bevacizumab; BKM120

Gastrointestinal Stromal Tumor Clinical Trial using AUY922

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- A Phase II Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor.
AUY922

Non Squamous Non Small Cell Lung Cancer Clinical Trial using OGX-427; Placebo

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- Double-Blind Randomized Phase II Trial of Carboplatin and Pemetrexed With or Without OGX-427 in Patients With Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer (The Spruce Clinical Trial).
OGX-427; Placebo

Diffuse Large B-Cell Lymphoma Clinical Trial using Bendamustine; Ofatumumab

SCRI Development Innovations, LLC - Recruiting 70 years or older.
- Phase II Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy.
Bendamustine; Ofatumumab

Metastatic Breast Cancer Clinical Trial using eribulin mesylate; Trastuzumab

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- Phase II Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy.
eribulin mesylate; Trastuzumab

Malignant Solid Tumour, or Gastroesophageal Cancer Clinical Trial using Tivantinib; FOLFOX

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- A Phase I/II Trial of the c-Met Inhibitor, Tivantinib, in Combination With FOLFOX for the Treatment of Patients With Advanced Solid Tumors (Phase I) and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal (GE) Junction, or Stomach (Phase II).
Tivantinib; FOLFOX

Chronic Lymphocytic Leukemia Clinical Trial using Ofatumumab

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia, a Phase II Trial.
Ofatumumab

Metastatic Breast Cancer With Intracranial Metastases Clinical Trial using cabazitaxel; lapatinib

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- Phase II Study With Lead-in Safety Cohort of Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases.
cabazitaxel; lapatinib